3Eising GP, Niemeyer M, Gunther T, et al. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery[J]. Eur J Cardiothorac Surg, 2001,20(2): 282-289.
3Shirai S, Kimura K. Lifestyle modification and diet therapy for nephrotic syndrome. Nippon Rinsho, 2004,62:1885-1891.
4Hebert PC, Wells G, Blajchman MA, et al. Amulticenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med, 1999,340:409-417.
5Hebert PC,Yetisir E,Martin C,et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med, 2001,29: 227-234.
6Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA, 2002,288:1499-1507.
7Isbister JP. Is the clinical significance of blood storage lesions underestimated? TATM, 2003,5: 356-362.
8Gan TJ. Intraoperative fluid management and choice of fluid. ASA 54th Ann Refresher Course Lectures, San Francisco, 2003. 236.
9McIlroy DR,Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg,2003,96:1572-1577.
10Friedman Z,Berkenstadt H,Preisman S,et al. A Comparison of lactated Ringer' s solution to hydroxyethy starch 6 % in a model of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg, 2003,96:39-45.
